Monovisc 88 MG/4 ML syringe 4ML
Ended Awarded
- Contract number
- SPE2DR26F1H85
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $9,089
Award facts
- Contract value 100% obligated
- $9,089.29 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $9,089.29 to AmerisourceBergen Drug Corp for the supply of Monovisc 88 mg/4 mL syringes on November 17, 2025, with an ultimate completion date of November 18, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Monovisc is a hyaluronic acid-based joint injection used primarily for osteoarthritis pain management, reflecting the Defense Logistics Agency's pharmaceutical supply chain requirements for military healthcare systems.
This delivery order falls under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 global pharmaceutical support vehicle running through December 2026. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen Drug Corp maintains an extensive portfolio of delivery orders with the Defense Logistics Agency, supplying a broad range of medications, vaccines, and medical devices to support military and veteran healthcare systems worldwide. The company's demonstrated capability to fulfill competitive federal procurements across multiple therapeutic domains positions it as a key supplier within the Department of Defense's medical supply chain infrastructure.
Quick answers
Who was awarded contract SPE2DR26F1H85?
SPE2DR26F1H85 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 17, 2025.
How much is contract SPE2DR26F1H85 worth?
The government has obligated $9,089 on SPE2DR26F1H85.
Is contract SPE2DR26F1H85 an order under another contract?
Yes. SPE2DR26F1H85 is a delivery order under SPE2DR25D2205, an indefinite delivery contract.
Was contract SPE2DR26F1H85 competed?
The extent of competition for SPE2DR26F1H85 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award